Expanding human healthspan

We are happy to hear from.

  • Investors seeking science-first biotech products
  • Companies interested in licensing validated formulations
  • Research organisations exploring in vivo platform collaborations
  • Media and press inquiries

Or write to

VivoArchitect Ibérica, S.L. (VivoXpand) uses your data to answer your enquiry. You can access, correct or delete it by writing to info@vivoxpand.com. More in our Privacy policy.